-60%

est. 2Y upside i

HealthcareSeries B

Rank

#1344

Sector

Healthtech / Virtual Care

Est. Liquidity

~3Y

Data Quality

Data: Medium

AmplifyMD presents a moderate upside opportunity for a job seeker, with an estimated 71.5% expected upside over a 2-year horizon.

Last updated: March 10, 2026

Bull (25%)+250%

AmplifyMD significantly expands its market penetration, driven by new strategic hospital partnerships and enhanced AI-enabled platform features, pushing ARR to ~$50M+ by 2028 and justifying a $630M+ valuation at a premium multiple due to its specialized focus and strong outcomes.

Base (40%)+75%

AmplifyMD maintains its strong growth trajectory, expanding its footprint within existing health systems and securing new partnerships, reaching ~$35M ARR by 2028. This steady performance justifies a $315M+ valuation, reflecting its solid market position and continued execution.

Bear (35%)-60%

Increased competition from large EHR vendors and well-funded telehealth platforms leads to slower customer acquisition and pricing pressure, causing growth to decelerate. A down round to ~$70M valuation wipes out most common stock value given the $43.6M in liquidation preferences.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Funding Intensity

24%

Investors hold approximately $43.6 million in liquidation preferences, meaning common stock holders would only see returns after this amount is paid out in an exit at or below the current $181M valuation.

Dilution Risk

moderate

As a Series B company, AmplifyMD will likely require at least one more significant funding round (Series C) before a liquidity event, leading to further dilution for current equity holders.

Secondary Liquidity

limited

A secondary market valuation of $181M exists, suggesting some limited opportunities for liquidity, but it is not described as active or frequent for all employees.

Questions to Ask at the Interview

Strategic questions based on Amplify MD's data — designed to show you've done your homework.

  • 1

    “Given the 'medium' incumbent threat from large EHR vendors like Epic and well-funded telehealth platforms, how does AmplifyMD plan to maintain and strengthen its competitive moat, particularly regarding its proprietary AI and deep EHR integrations?”

  • 2

    “With a hybrid revenue model and significant TAM, what are the key metrics AmplifyMD is focused on to demonstrate scalable and profitable growth, especially as it expands its platform and physician network?”

  • 3

    “Considering the Series B funding and the stated 2-year horizon for upside/downside, what is the company's anticipated timeline for a liquidity event, and how does AmplifyMD plan to manage employee equity value through potential future dilution?”

Community

Valuation Sentiment

Our model estimates -60% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.